|
Clinical Research Detail |
|
Title Of Study |
IAVI P001: A Phase I trial where the volunteers are randomly allocated in a blinded manner to 2 groups to receive either TBC-M4, a multigenic MVA HIV Vaccine or ADVAX, a multigenic DNA HIV Vaccine followed by TBC-M4, a multigenic MVA HIV Vaccine or placebo to evaluate the Safety and Immunogenicity of TBC-M4 or ADVAX followed by TBC-M4.
|
|
Disease Condition |
Human Immunodeficiency Virus (HIV)
|
|
Phase of Trial |
Phase-1
|
Discipline |
Immunology
|
|
Start date of Trial |
4/1/2009
|
Closing Date of Trial |
4/1/2011
|
|
|
If you are a doctor interested in clinical research then upload your profile. Click
here
|
If you are a hospital interested in clinical research then upload your profile. Click
here
|
If you are a patient interested to know more about this clinical trial mail us at:
[email protected]
|